These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 21521342)

  • 1. Optimizing glucocorticoid replacement therapy in severely adrenocorticotropin-deficient hypopituitary male patients.
    Behan LA; Rogers B; Hannon MJ; O'Kelly P; Tormey W; Smith D; Thompson CJ; Agha A
    Clin Endocrinol (Oxf); 2011 Oct; 75(4):505-13. PubMed ID: 21521342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conventional glucocorticoid replacement overtreats adult hypopituitary patients with partial ACTH deficiency.
    Agha A; Liew A; Finucane F; Baker L; O'Kelly P; Tormey W; Thompson CJ
    Clin Endocrinol (Oxf); 2004 Jun; 60(6):688-93. PubMed ID: 15163331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low-dose hydrocortisone replacement is associated with improved arterial stiffness index and blood pressure dynamics in severely adrenocorticotrophin-deficient hypopituitary male patients.
    Behan LA; Carmody D; Rogers B; Hannon MJ; Davenport C; Tormey W; Smith D; Thompson CJ; Stanton A; Agha A
    Eur J Endocrinol; 2016 Jun; 174(6):791-9. PubMed ID: 27025241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low-dose hydrocortisone replacement therapy is associated with improved bone remodelling balance in hypopituitary male patients.
    Behan LA; Kelleher G; Hannon MJ; Brady JJ; Rogers B; Tormey W; Smith D; Thompson CJ; McKenna MJ; Agha A
    Eur J Endocrinol; 2014 Jan; 170(1):141-50. PubMed ID: 24123094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glucocorticoid replacement therapy and fibrinolysis in patients with hypopituitarism.
    Peacey SR; Wright D; Aye M; Moisey R
    Clin Endocrinol (Oxf); 2012 Jul; 77(1):94-8. PubMed ID: 22151005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized, double-blind, crossover study comparing two- and four-dose hydrocortisone regimen with regard to quality of life, cortisol and ACTH profiles in patients with primary adrenal insufficiency.
    Ekman B; Bachrach-Lindström M; Lindström T; Wahlberg J; Blomgren J; Arnqvist HJ
    Clin Endocrinol (Oxf); 2012 Jul; 77(1):18-25. PubMed ID: 22288685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-physiological levels of circulating cortisol in growth hormone-treated hypopituitary adults after conventional cortisone substitution.
    Blomgren J; Ekman B; Andersson PO; Arnqvist HJ
    Scand J Clin Lab Invest; 2004 Apr; 64(2):132-9. PubMed ID: 15115251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prolonged hypocortisolemia in hydrocortisone replacement regimens in adrenocorticotrophic hormone deficiency.
    Maguire AM; Ambler GR; Moore B; McLean M; Falleti MG; Cowell CT
    Pediatrics; 2007 Jul; 120(1):e164-71. PubMed ID: 17576782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hydrocortisone replacement therapy in children and adolescents with hypopituitarism.
    DeVile CJ; Stanhope R
    Clin Endocrinol (Oxf); 1997 Jul; 47(1):37-41. PubMed ID: 9302370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The modulation of corticosteroid metabolism by hydrocortisone therapy in patients with hypopituitarism increases tissue glucocorticoid exposure.
    Sherlock M; Behan LA; Hannon MJ; Alonso AA; Thompson CJ; Murray RD; Crabtree N; Hughes BA; Arlt W; Agha A; Toogood AA; Stewart PM
    Eur J Endocrinol; 2015 Nov; 173(5):583-93. PubMed ID: 26264718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth hormone treatment in hypopituitary GH deficient adults reduces circulating cortisol levels during hydrocortisone replacement therapy.
    Rodríguez-Arnao J; Perry L; Besser GM; Ross RJ
    Clin Endocrinol (Oxf); 1996 Jul; 45(1):33-7. PubMed ID: 8796136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of growth hormone deficiency and replacement on glucocorticoid exposure in hypopituitary patients on cortisone acetate and hydrocortisone replacement.
    Swords FM; Carroll PV; Kisalu J; Wood PJ; Taylor NF; Monson JP
    Clin Endocrinol (Oxf); 2003 Nov; 59(5):613-20. PubMed ID: 14616886
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of growth hormone replacement on cortisol metabolism and glucocorticoid sensitivity in hypopituitary adults.
    Weaver JU; Thaventhiran L; Noonan K; Burrin JM; Taylor NF; Norman MR; Monson JP
    Clin Endocrinol (Oxf); 1994 Nov; 41(5):639-48. PubMed ID: 7828353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adrenal gland hypofunction in active polymyalgia rheumatica. effect of glucocorticoid treatment on adrenal hormones and interleukin 6.
    Cutolo M; Straub RH; Foppiani L; Prete C; Pulsatelli L; Sulli A; Boiardi L; Macchioni P; Giusti M; Pizzorni C; Seriolo B; Salvarani C
    J Rheumatol; 2002 Apr; 29(4):748-56. PubMed ID: 11950017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreased quality of life (QoL) in hypopituitary patients: involvement of glucocorticoid replacement and radiation therapy.
    Ajmal A; McKean E; Sullivan S; Barkan A
    Pituitary; 2018 Dec; 21(6):624-630. PubMed ID: 30349995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hair cortisol content in patients with adrenal insufficiency on hydrocortisone replacement therapy.
    Gow R; Koren G; Rieder M; Van Uum S
    Clin Endocrinol (Oxf); 2011 Jun; 74(6):687-93. PubMed ID: 21521272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of two replacement regimens in primary adrenal insufficiency patients. effect on clinical symptoms, health-related quality of life and biochemical parameters.
    Alonso N; Granada ML; Lucas A; Salinas I; Reverter J; Oriol A; Sanmarti A
    J Endocrinol Invest; 2004 May; 27(5):449-54. PubMed ID: 15279078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circadian hormone profiles and insulin sensitivity in patients with Addison's disease: a comparison of continuous subcutaneous hydrocortisone infusion with conventional glucocorticoid replacement therapy.
    Björnsdottir S; Øksnes M; Isaksson M; Methlie P; Nilsen RM; Hustad S; Kämpe O; Hulting AL; Husebye ES; Løvås K; Nyström T; Bensing S
    Clin Endocrinol (Oxf); 2015 Jul; 83(1):28-35. PubMed ID: 25400085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute effect of increasing glucocorticoid replacement dose on cardiovascular risk and insulin sensitivity in patients with adrenocorticotrophin deficiency.
    Petersons CJ; Mangelsdorf BL; Thompson CH; Burt MG
    J Clin Endocrinol Metab; 2014 Jun; 99(6):2269-76. PubMed ID: 24606100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of glucocorticoid replacement therapy on glucose tolerance and intermediary metabolites in hypopituitary adults.
    al-Shoumer KA; Beshyah SA; Niththyananthan R; Johnston DG
    Clin Endocrinol (Oxf); 1995 Jan; 42(1):85-90. PubMed ID: 7889636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.